Oct 10, 2025
Sharper vision starts here
Sharper vision starts here Author(s)Jack M. Chapman, MD Fact checked by: Sheryl Stevenson Key Takeaways Over 75% of cataract patients have …
Resources
Oct 10, 2025
Seeing Stars: Gould & Steele interview
Permission was given by Martha Steele & Ellen Gould to share this podcast.
Oct 8, 2025
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
Publication|Articles|October 6, 2025 Optometry Times Journal September/October digital edition 2025- Volume 17 – Issue 05 Author(s)Lynda Charters Fact checked by: Karen S. …
Sep 26, 2025
Seeing Through the Fog: Understanding Macular Degeneration
Helping with reading, driving, and daily tasks, caregivers often serve as the ‘eyes’ for their loved ones By: Paul Wynn,AARP …
Sep 23, 2025
New eyedrop raises hopes for less invasive treatment of serious vision conditions
A new eyedrop has shown early success in delivering protective compounds to where they’re needed most in the eye, raising …
Sep 23, 2025
Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration
Adult Stem Cells Show Therapeutic Promise in Treating Vision Loss From Macular Degeneration by: Michigan Medicine-University of Michigan Newswise — …
Sep 16, 2025
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Recruiting- Phase 2 ClinicalTrials.gov IDNCT06635148 SponsorJanssen Research & Development, LLC Information Provided byJanssen Research & Development, LLC Clinical Trial Study …
Sep 16, 2025
FDA fast tracks SAR402663 intravitreal gene therapy for wet AMD
By:Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR402663 is a one-time intravitreal gene therapy designed to reduce …
Sep 12, 2025
Sight Science’s TearCare System earns spot in TFOS DEWS III dry eye report
Author(s): Martin David Harp Key Takeaways TearCare System’s inclusion in TFOS DEWS III report validates its clinical efficacy and role …
Sep 9, 2025
A study of the progression of sensitivity loss in GA over time using inferred data
Author(s): Lynda Charters Key Takeaways Inferred sensitivity mapping predicts retinal function in GA with high spatial resolution, avoiding extensive psychophysical …
Sep 2, 2025
First patient dosed in Qlaris Bio’s phase 2 Nightingale clinical trial for QLS-111
By: Jordana Joy, Associate Editor The study will be evaluating the safety, tolerability, and efficacy of QLS-111 in adult patients …
Sep 2, 2025
Inside genetics and glaucoma
August 28, 2025 By Kyra Dorgeloh, OD, FAAO Thomas A. Wong, OD, FAAO Glaucoma is a general term for a diverse …
Aug 26, 2025
VG801 receives regenerative medicine advanced therapy designation for Stargardt disease
By: Alex Young Fact checked by : Christine Klimanskis, ELS Key takeaways: VG801 is a dual-AAV gene therapy in development for …
Aug 15, 2025
What the eyes reveal: Cardiovascular clues in women—hidden in plain sight
Author(s): Lynda Charters Fact checked by: Karen S. DeLoss, OD, FAAO Key Takeaways Ocular exams can reveal cardiovascular health issues, …
Aug 12, 2025
Cosmetic procedures associated with serious ophthalmologic complications
Author(s): Lynda Charters Key Takeaways Minimally invasive cosmetic procedures can cause rare but severe ophthalmological complications, including irreversible vision loss …
Aug 11, 2025
EyePoint completes enrollment in second phase 3 trial of sustained-release AMD therapy
ByJay S. Duker, MD ByAlex Young ByAnthony DeFino Fact checked by Christine Klimanskis, ELS Key takeaways: More than 400 patients …
Aug 11, 2025
This common fruit has over 1,600 compounds that boost brain, heart, and gut health
Published August 6, 2025 | Originally published on ScienceDaily Top Health A new article appearing in the current issue of the peer-reviewed Journal of …
Aug 6, 2025
Study supports Iluvien as ‘long-acting option’ in diabetic macular edema
Key takeaways: The NEW DAY study did not meet its primary endpoint but showed good outcomes in secondary endpoints. A …
Aug 5, 2025
Geographic Atrophy Patient Experience Research
A new study is being conducted on geographic atrophy. They would like to hear about your experience with the drug …
Jul 31, 2025
Phase 3 study of LUMIFY Preservative Free and LUMIFY eye drops meets primary end point
Author(s): Jordana Joy Key Takeaways LUMIFY Preservative Free eye drops are statistically non-inferior to LUMIFY in reducing ocular redness, with …
Jul 28, 2025
VA-developed RainDrop Dispenser Aid aims to simplify use of single-use eye drops for patients with arthritis, tremors July 24, 2025
July 24, 2025 by Lynda Charters, Jordana Joy, Associate Editor Rain Eye Drops LLC announced the launch of a newly …
Jul 24, 2025
Novel AI-powered retina tracker detects eye disease in under one second
By: The Endocrine Society A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according …
Jul 24, 2025
Oral danegaptide for diabetic retinopathy successfully completes phase 1b trial
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Danegaptide could be an oral therapy for patients with …
Jul 24, 2025
Survey finds majority of US patients delaying eye care despite experiencing poor eyesight, eye health
By: Jordana Joy, Associate Editor Survey participants cited cost concerns, perceived inevitability, and deprioritization as obstacles to receiving eye care.
Jul 24, 2025
FDA fast tracks one-time intravitreal gene therapy for geographic atrophy
By: Anthony DeFino Fact checked by: Christine Klimanskis, ELS Key takeaways: SAR446597 is designed to inhibit C1s and factor Bb …
Jul 8, 2025
Alcon to acquire LumiThera and its photobiomodulation device for the treatment of dry AMD
Author(s): Martin David Harp Key Takeaways Alcon’s acquisition of LumiThera includes a PBM device for early and intermediate dry AMD, …
Jul 8, 2025
Can you eye doctor predict an impending stroke?
A university study shows certain types of retina problems are early signs of stroke. Research scientists from the University of …
Jul 3, 2025
Happy Independence Day
The Macular Degeneration Association would like to wish everyone a safe and excellent 4th of July. The offices …
Jun 30, 2025
36-month results from phase 1/2a clinical study of RG6501 released
Author(s): Kassi Filkins Key Takeaways RG6501 (OpRegen) cell therapy shows sustained visual acuity and retinal structure improvements in GA patients …
Jun 30, 2025
Redefining retinal care: Ixo-vec gene therapy for nAMD enters phase 3
Author(s): Glenn Yiu, MD, PhD Fact checked by: Sheryl Stevenson Frequent intravitreal injections for neovascular age-related macular degeneration present a …